Immatics (IMTX) Total Current Liabilities (2019 - 2025)
Immatics (IMTX) reported Total Current Liabilities of $50.1 million for Q4 2025, down 31.08% on a YoY basis from $72.7 million in Q4 2024, and down 31.21% sequentially from $72.8 million in Q3 2025.
Immatics (IMTX) Total Current Liabilities (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Total Current Liabilities data on file, last reported at $50.1 million in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities fell 31.08% year-over-year to $50.1 million; the trailing twelve-month figure through Dec 2025 stood at $50.1 million (down 31.08% YoY), and the FY2025 full-year result was $48.6 million, down 33.96% from the prior year.
- Total Current Liabilities eased to $50.1 million in Q4 2025, from $72.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $168.4 million in Q4 2023 to a low of $50.1 million in Q4 2025.
- A 5-year average of $111.9 million and a median of $111.0 million in 2021 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 55.09% in 2023 and sank 63.78% in 2025, its largest moves.
- Tracing IMTX's Total Current Liabilities over 5 years: stood at $108.8 million in 2021, then slipped by 0.22% to $108.6 million in 2022, then soared by 55.09% to $168.4 million in 2023, then sank by 56.87% to $72.7 million in 2024, then plunged by 31.08% to $50.1 million in 2025.
- Business Quant data shows IMTX's Total Current Liabilities at $50.1 million in Q4 2025, $72.8 million in Q3 2025, and $64.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 66.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 13.42 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.81 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 289.60 Mn |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | 50.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.07 Mn |
| Sep 30, 2025 | 72.78 Mn |
| Jun 30, 2025 | 64.80 Mn |
| Mar 31, 2025 | 58.66 Mn |
| Dec 31, 2024 | 72.65 Mn |
| Sep 30, 2024 | 141.57 Mn |
| Jun 30, 2024 | 161.04 Mn |
| Mar 31, 2024 | 161.98 Mn |
| Dec 31, 2023 | 168.44 Mn |
| Sep 30, 2023 | 131.88 Mn |
| Jun 30, 2023 | 135.36 Mn |
| Mar 31, 2023 | 107.96 Mn |
| Dec 31, 2022 | 108.61 Mn |
| Sep 30, 2022 | 125.15 Mn |
| Jun 30, 2022 | 121.64 Mn |
| Mar 31, 2022 | 103.09 Mn |
| Dec 31, 2021 | 108.85 Mn |
| Sep 30, 2021 | 126.33 Mn |
| Jun 30, 2021 | 113.12 Mn |
| Mar 31, 2021 | 103.84 Mn |